• Our Vision is to improve healthcare as a global provider of innovative and reliable diagnostic tests.
  • Our Mission is to identify and develop novel patentable diagnostic markers and technologies which can be commercialised to meet clinical needs, both in the laboratory and at the point of care.
  • We will collaborate with partners, create branded products and identify complementary businesses which support our objective of continuing to grow as a respected and profitable healthcare company.
  • Our Values include meeting all current and future regulatory, quality and environmental standards appropriate for our industry and the countries in which we operate.

Axis-Shield addresses and contact details:

For all enquiries relating to our Afinion, Nycocard and Density Gradient Media products, please contact our POC Division:

 

Axis-Shield Point-of-Care Division
Kjelsåsveien 161
N-0884 Oslo
Norway
T: +47 24 05 60 00
email Point-of-Care Division  

 

 

For all enquiries relating to our Laboratory products please contact our Laboratory Division:

 

Axis-Shield Laboratory Division
Luna Place
The Technology Park
Dundee DD2 1XA
Scotland
T: +44 (0)1382 422000
F: +44 (0)1382 422088
email Laboratory Division

Registered number: SC145200

 

Axis-Shield at a Glance

A pioneering organisation focused on the development and manufacturing of important and innovative in vitro diagnostic tests for use in clinical laboratories and at the point of care.

› More about our tests

Focus on Homocysteine

As a general marker of overall health status, few tests carry greater predictive weight than Homocysteine. The amount of Homocysteine in your blood is one of the best independent indicators of how healthy you are.

 

› Axis-Shield Homocysteine assays

© Axis-Shield plc 2011. All rights reserved. Registered in Scotland No. SC145200 - Sitemap | Terms-of-Use | Accessibility | Disclaimer
Luna Place, The Technology Park, Dundee, DD2 1XA, Scotland.
Diagnostics for the laboratory & the point of care in areas of clinical need including diabetes, cardiovascular & neurodegenerative disease, rheumatoid arthritis & infectious disease.